PofoliaShared via Pofolia

Stroke· 2016Q1

Poststroke Depression: A Scientific Statement for Healthcare Professionals From the American Heart Association/American Stroke Association

Amytis Towfighi, Bruce Ovbiagele, Nada El Husseini, Maree L. Hackett et al.

Short summary

Poststroke depression (PSD) affects approximately one-third of stroke survivors, increasing risks for poor recovery, recurrent events, reduced quality of life, and mortality.

AI-generated from the title and abstract; the full text is not read.

Key points

  • Approximately one-third of stroke survivors experience poststroke depression (PSD).
  • PSD is linked to higher risks of poor recovery, recurrent vascular events, reduced quality of life, and mortality.
  • This statement is the first comprehensive review of PSD from the American Heart Association.
  • It covers epidemiology, pathophysiology, outcomes, management, and prevention, identifying knowledge gaps.

AI-generated from the title and abstract; the full text is not read.

Abstract

Poststroke depression (PSD) is common, affecting approximately one third of stroke survivors at any one time after stroke. Individuals with PSD are at a higher risk for suboptimal recovery, recurrent vascular events, poor quality of life, and mortality. Although PSD is prevalent, uncertainty remains regarding predisposing risk factors and optimal strategies for prevention and treatment. This is the first scientific statement from the American Heart Association on the topic of PSD. Members of the writing group were appointed by the American Heart Association Stroke Council's Scientific Statements Oversight Committee and the American Heart Association's Manuscript Oversight Committee. Members were assigned topics relevant to their areas of expertise and reviewed appropriate literature, references to published clinical and epidemiology studies, clinical and public health guidelines, authoritative statements, and expert opinion. This multispecialty statement provides a comprehensive review of the current evidence and gaps in current knowledge of the epidemiology, pathophysiology, outcomes, management, and prevention of PSD, and provides implications for clinical practice.

The authors' abstract, as published at the source. Stroke, 2016 · DOI ↗

TakeawaysPremium
Ask the paperFree account

Continue with a free account

Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.

Continue free on the web

Sign in with Google or Apple; no card needed. You come back to this paper.

On your phone:

Field: Rehabilitation

RehabilitationMedicine